KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Sales (2016 - 2025)

Emergent BioSolutions (EBS) has 15 years of Return on Sales data on record, last reported at 0.37% in Q4 2025.

  • For Q4 2025, Return on Sales fell 21.0% year-over-year to 0.37%; the TTM value through Dec 2025 reached 0.07%, up 30.0%, while the annual FY2025 figure was 0.07%, 25.0% up from the prior year.
  • Return on Sales reached 0.37% in Q4 2025 per EBS's latest filing, down from 0.22% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.39% in Q3 2024 and bottomed at 5.66% in Q2 2024.
  • Average Return on Sales over 5 years is 0.44%, with a median of 0.14% recorded in 2021.
  • Peak YoY movement for Return on Sales: plummeted -489bps in 2024, then soared 558bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.24% in 2021, then tumbled by -195bps to 0.23% in 2022, then increased by 22bps to 0.18% in 2023, then rose by 10bps to 0.16% in 2024, then plummeted by -128bps to 0.37% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.37% in Q4 2025, 0.22% in Q3 2025, and 0.09% in Q2 2025.